Basavarajappa BS et al. |
Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. |
2000 |
Biochim. Biophys. Acta |
pmid:11113634
|
Pryor SR |
Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal. |
2000 |
Med. Hypotheses |
pmid:11090297
|
Rhee MH et al. |
Functional role of tryptophan residues in the fourth transmembrane domain of the CB(2) cannabinoid receptor. |
2000 |
J. Neurochem. |
pmid:11080201
|
Sugiura T and Waku K |
2-Arachidonoylglycerol and the cannabinoid receptors. |
2000 |
Chem. Phys. Lipids |
pmid:11106784
|
Gallily R et al. |
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. |
2000 |
Eur. J. Pharmacol. |
pmid:11011050
|
Chen Y et al. |
Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. |
2000 |
Circ. Res. |
pmid:10948067
|
Suhara Y et al. |
Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. |
2000 |
Chem. Pharm. Bull. |
pmid:10923815
|
Járai Z et al. |
Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. |
2000 |
Hypertension |
pmid:10679517
|
Kozak KR et al. |
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. |
2000 |
J. Biol. Chem. |
pmid:10931854
|
Ameri A and Simmet T |
Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10731038
|
Jarrahian A et al. |
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. |
2000 |
J. Neurochem. |
pmid:10820223
|
Gonsiorek W et al. |
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. |
2000 |
Mol. Pharmacol. |
pmid:10779390
|
Beltramo M and Piomelli D |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. |
2000 |
Neuroreport |
pmid:10817598
|
Maccarrone M et al. |
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11095952
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Howlett AC and Mukhopadhyay S |
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. |
2000 |
Chem. Phys. Lipids |
pmid:11106782
|
Martin BR et al. |
Cannabinoid properties of methylfluorophosphonate analogs. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10945879
|
Hillard CJ |
Endocannabinoids and vascular function. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10871291
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|